We are live on ! Find out more
EFTR

eFFECTOR Therapeutics, Inc. Common Stock
EFTR

Delisted

EFTR was delisted on the 2nd of July, 2024.

Back to rankings

43 hedge funds and large institutions have $80.3M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+43
Holders Change %
–
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ECP
Empyrean Capital Partners
California
+$9.82M
2
LA
Linden Advisors
New York
+$8.93M
3
MI
MMCAP International
Cayman Islands
+$4.91M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.91M
5
PC
Periscope Capital
Ontario, Canada
+$4.51M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ECP
1
Empyrean Capital Partners
California
$9.7M +$9.82M +40,000 New
LA
2
Linden Advisors
New York
$8.83M +$8.93M +36,368 New
MI
3
MMCAP International
Cayman Islands
$4.87M +$4.91M +20,000 New
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$4.87M +$4.91M +20,000 New
PC
5
Periscope Capital
Ontario, Canada
$4.45M +$4.51M +18,374 New
RCM
6
Radcliffe Capital Management
Pennsylvania
$3.73M +$3.78M +15,390 New
AFM
7
Anson Funds Management
Texas
$3.2M +$3.22M +13,132 New
SC
8
Sculptor Capital
New York
$3.05M +$3.07M +12,500 New
Blackstone Inc
9
Blackstone Inc
New York
$2.92M +$2.95M +12,000 New
LP
10
LMR Partners
United Kingdom
$2.92M +$2.95M +12,000 New
FTCM
11
Fir Tree Capital Management
New York
$2.92M +$2.95M +12,000 New
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$2.92M +$2.95M +12,000 New
WP
13
Woodline Partners
California
$2.71M +$2.77M +11,271 New
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$2.58M +$2.61M +10,628 New
Citadel Advisors
15
Citadel Advisors
Florida
$2.26M +$2.28M +9,299 New
PSAMP
16
P. Schoenfeld Asset Management (PSAM)
New York
$1.95M +$1.96M +8,000 New
CH
17
CVI Holdings
Delaware
$1.92M +$1.96M +8,000 New
SCM
18
Saba Capital Management
New York
$1.62M +$1.63M +6,656 New
KIM
19
Karpus Investment Management
New York
$1.3M +$1.33M +5,406 New
SSA
20
Schonfeld Strategic Advisors
New York
$1.24M +$1.26M +5,131 New
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$975K +$982K +4,000 New
BCM
22
Basso Capital Management
Connecticut
$975K +$982K +4,000 New
MP
23
Mangrove Partners
Connecticut
$975K +$982K +4,000 New
TCM
24
Tenor Capital Management
New York
$975K +$982K +4,000 New
WA
25
Whitebox Advisors
Minnesota
$973K +$982K +4,000 New
1
2

EFTR Hedge Fund Activity: Q1 2021 in Review

43 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Common Stock (EFTR) for Q1 2021, worth a combined $80.3M.

Buyers outnumbered sellers: 43 funds opened new EFTR positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $9.82M.

  • 43 institutional investors held eFFECTOR Therapeutics, Inc. Common Stock (EFTR) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $80.3M of eFFECTOR Therapeutics, Inc. Common Stock stock for Q1 2021.
  • 43 funds opened new eFFECTOR Therapeutics, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +43 holders.
  • The largest eFFECTOR Therapeutics, Inc. Common Stock buyer in Q1 2021 was Empyrean Capital Partners, an estimated $9.82M added.

Based on aggregated 13F filings for Q1 2021.